D. Boral Capital Acted as Exclusive Placement Agent to NanoViricides, Inc. (NYSE: NNVC) in Connection with its ~$3.8 Million Registered Direct Offering
Transaction Information On July 27, 2026, NanoViricides, Inc. (NYSE: NNVC) (“NNVC” or the “Company”) a clinical stage, leading global pioneer












